Table 1 Baseline characteristics before and after matching
Before Matching | Before Matching | ||||||
|---|---|---|---|---|---|---|---|
Non-AKI (n = 1529) | AKI (n = 302) | P-value | Non-AKI (n = 838) | AKI (n = 301) | P-value | ||
Demographic | |||||||
Age (Year) | 64.08 (13.30) | 65.61 (12.81) | 0.066 | 64.70 (13.36) | 65.64 (12.82) | 0.293 | |
Sex (Male) | 1060 (69.3) | 202 (66.9) | 0.442 | 593 (70.8) | 201 (66.8) | 0.223 | |
Vital signs | |||||||
HR (minˉ¹) | 83.96 (17.25) | 88.74 (19.72) | < 0.001 | 87.53 (18.46) | 88.67 (19.72) | 0.366 | |
RR (minˉ¹) | 18.27 (5.33) | 19.04 (5.31) | 0.023 | 18.81 (5.67) | 19.03 (5.31) | 0.552 | |
SBP (mmHg) | 124.68 (21.95) | 120.96 (25.21) | 0.009 | 123.54 (22.35) | 121.10 (25.14) | 0.117 | |
DBP (mmHg) | 71.23 (15.92) | 70.04 (17.35) | 0.242 | 70.92 (16.09) | 70.12 (17.32) | 0.473 | |
MAP (mmHg) | 89.06 (16.03) | 87.01 (18.02) | 0.047 | 88.47 (16.37) | 87.11 (17.97) | 0.228 | |
T (°C) | 36.60 [36.10, 36.90] | 36.55 [36.10, 37.00] | 0.635 | 36.60 [36.10, 36.90] | 36.60 [36.10, 37.00] | 0.433 | |
Medication (n%) | |||||||
Aspirin | 1333 (87.2) | 263 (87.1) | 1 | 721 (86.0) | 262 (87.0) | 0.736 | |
Clopidogrel | 942 (61.6) | 162 (53.6) | 0.012 | 512 (61.1) | 162 (53.8) | 0.033 | |
RAASi | 437 (28.6) | 67 (22.2) | 0.028 | 230 (27.4) | 67 (22.3) | 0.093 | |
MRA | 59 (3.9) | 13 (4.3) | 0.84 | 45 (5.4) | 13 (4.3) | 0.576 | |
β-blocker | 1266 (82.8) | 238 (78.8) | 0.116 | 681 (81.3) | 238 (79.1) | 0.458 | |
Comorbidities (n%) | |||||||
Hypertension | 546 (35.7) | 101 (33.4) | 0.492 | 293 (35.0) | 101 (33.6) | 0.711 | |
T2DM | 226 (14.8) | 55 (18.2) | 0.154 | 113 (13.5) | 55 (18.3) | 0.056 | |
AF | 215 (14.1) | 62 (20.5) | 0.005 | 163 (19.5) | 62 (20.6) | 0.731 | |
CKD | 121 (7.9) | 34 (11.3) | 0.073 | 77 (9.2) | 34 (11.3) | 0.345 | |
OSA | 51 (3.3) | 14 (4.6) | 0.344 | 23 (2.7) | 14 (4.7) | 0.158 | |